Claret Asset Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
4,157
-1,083
-21% -$52.7K 0.02% 364
2026
Q1
$225K Buy
5,240
+1
+0% +$43 0.03% 299
2025
Q4
$230K Sell
5,239
-12
-0.2% -$496 0.03% 305
2025
Q3
$217K Sell
5,251
-75
-1% -$3.02K 0.03% 358
2025
Q2
$235K Buy
+5,326
New +$213K 0.03% 242
2025
Q1
Sell
-9,012
Closed -$321K 133
2024
Q4
$300K Buy
9,012
+63
+0.7% +$2.04K 0.05% 130
2024
Q3
$232K Buy
8,949
+47
+0.5% +$1.17K 0.04% 204
2024
Q2
$200K Buy
+8,902
New +$197K 0.04% 226

Other funds holding EXEL

Claret Asset Management's EXEL Position: Q2 2026 in Review

Claret Asset Management reduced its Exelixis (EXEL) stake by 21% in Q2 2026, selling an estimated $52.7K and leaving 4,157 shares worth $226K. The position accounts for 0.02% of the portfolio, ranked #364.

Claret Asset Management first reported a position in EXEL in Q2 2024 and has held it in 8 quarters since. The position peaked at $300K in Q4 2024. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Claret Asset Management held 4,157 shares of Exelixis worth $226K as of Q2 2026.
  • Claret Asset Management sold 1,083 Exelixis shares in Q2 2026, an estimated $52.7K.
  • Exelixis made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #364 holding.
  • Claret Asset Management first reported a position in Exelixis in Q2 2024 and has held it in 8 quarters since.
  • Claret Asset Management's Exelixis position peaked at $300K in Q4 2024.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.